64 related articles for article (PubMed ID: 21198575)
21. Using a Genetic Risk Score Approach to Predict Headache Response to Triptans in Migraine Without Aura.
Cargnin S; Viana M; Sances G; Cantello R; Tassorelli C; Terrazzino S
J Clin Pharmacol; 2019 Feb; 59(2):288-294. PubMed ID: 30256423
[TBL] [Abstract][Full Text] [Related]
22. Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans.
Cargnin S; Viana M; Mittino D; Bellomo G; Tassorelli C; Nappi G; Canonico PL; Terrazzino S
Neurol Sci; 2014 Mar; 35(3):421-7. PubMed ID: 24030684
[TBL] [Abstract][Full Text] [Related]
23. Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan.
Bigal ME; Kolodner KB; Lafata JE; Leotta C; Lipton RB
Cephalalgia; 2006 Jan; 26(1):43-9. PubMed ID: 16396665
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the efficacy of migraine therapy.
Chawluk JB
Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
[TBL] [Abstract][Full Text] [Related]
25. Sumatriptan causes parallel decrease in plasma CGRP concentration and migraine headache during nitroglycerin-induced migraine attack.
Vanmolkot F; Van der Schueren B; de Hoon J
Cephalalgia; 2006 Aug; 26(8):1037-8; author reply 1038-9. PubMed ID: 16886948
[No Abstract] [Full Text] [Related]
26. A comparison of familial and sporadic migraine in a headache clinic population.
Rainero I; Valfrè W; Gentile S; Lo Giudice R; Ferrero M; Savi L; Pinessi L
Funct Neurol; 2002; 17(4):193-7. PubMed ID: 12675262
[TBL] [Abstract][Full Text] [Related]
27. [Migraine or headache management: a pharmacy survey].
Desamericq G; Revol A; Laforest L; Chamba G; Bauguil G; Ritleng C; Van Ganse E
Therapie; 2009; 64(6):395-403. PubMed ID: 20025843
[TBL] [Abstract][Full Text] [Related]
28. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
29. Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans.
Zeller JA; Lindner V; Frahm K; Baron R; Deuschl G
Cephalalgia; 2005 Jul; 25(7):536-41. PubMed ID: 15955041
[TBL] [Abstract][Full Text] [Related]
30. Frovatriptan and data publication.
Tfelt-Hansen P
Headache; 2008 Oct; 48(9):1382-3. PubMed ID: 19006553
[No Abstract] [Full Text] [Related]
31. Efficacy and tolerability of almotriptan in menstrual migraine: a comment.
Lionetto L; Fiorillo M; Martelletti P
Expert Opin Pharmacother; 2011 Oct; 12(15):2279-81. PubMed ID: 21916785
[No Abstract] [Full Text] [Related]
32. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of cervicogenic headache and migraine without aura (?).
Sjaastad O; Fredriksen T; Pareja JA; Stolt-Nielsen A; Vincent M
Funct Neurol; 1999; 14(4):209-18. PubMed ID: 10713894
[TBL] [Abstract][Full Text] [Related]
35. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
36. Effect of sumatriptan on health care resource use among patients with migraine.
Joish VN; Cady PS
Manag Care Interface; 2001 Jan; 14(1):68-72. PubMed ID: 11214537
[TBL] [Abstract][Full Text] [Related]
37. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].
MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980
[No Abstract] [Full Text] [Related]
38. Improvements in health-related quality of life with sumatriptan treatment for migraine.
Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
[TBL] [Abstract][Full Text] [Related]
39. [Triptans in migraine: from clinical view].
Manaka S
No To Shinkei; 2004 Sep; 56(9):739-45. PubMed ID: 15552862
[No Abstract] [Full Text] [Related]
40. Zolmitriptan.
Can Fam Physician; 1999 Jun; 45():1491-4, 1497-501. PubMed ID: 10386213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
